PDF file: EURASNET Annual Report 2008

267 GROUP 16 (CARMO- 12 F. Baralle O CO 48FONSECA) is planning toidentify cancer-specificsplicing factor geneexpression signatures andnovel cancer-specificalternative splicing events(planned for month 48).268 Four Workshops in 2009 16 Beggs O PU 37-48269 Four Interdisciplinary focus 16 Beggs O PU 37-48meetings planned for 2009.270 Prepare Annual Report for2009 period (month 50).22 Lührmann R CO 50271 Comparison of HJAY andExonArray analysis of at leasttwo further experiments e.g.hSlu7 knockdown (Ast),U2AF35 knockdown (Carmo-Fonseca), Parkinson’s diseasepatients (Soreq). (month 50)272 2010 Second InternationalMeeting/ Fifth AnnualMeeting, April, location to bedecided273 Prepare further content onsplicing-related diseases withinput from clinicians (month54)274 Maintain up-to-date websitecontent/news etc. onEURASNET activities(month 54)275 Liaise with EURASNETclinical contacts to developfurther targeted informationfor this group (month 54).276 Tools and resourcesrepository updated (month54). continuation of 150277 Maintenance andimplementation ofimprovements in ASTD(month 54).278 Maintain and further expandthe informationpackage/forum within theEURASNET website andmeetings with updatedannouncements on fundingpossibilities. (month 54,continuation of 157)279 Maintain and further expandthe liaison with relevantbodies at both national andEU level. (month 54,continuation of 158)280 Continue to investigateputative mRNA targets oforphan snoRNAs (JBrown).281 Computational structuralmodel of splicing regulators.282 Comparative analysis of thegene landscape.8 Smith O CO 5016 Beggs R PU/CO 521 Brown O CO 541 Brown O PU 541 Brown O PU 541 Brown O CO 544 Apweiler O PU 545 Carmo-Fonseca5 Carmo-FonsecaO CO 54O CO 546 Ast O CO 546 Ast O CO 546 Ast O CO 54238